Krish S. Sardesai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Krish S. Sardesai has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Kyle N. Kunze
Midwest Orthopaedics at Rush University Chicago Illinois U.S.A.
3 shared publications Brian J. Cole
Midwest Orthopaedics at Rush Chicago Illinois U.S.A.
2 shared publicationsJason E. Jesse
Midwest Orthopaedics at Rush Chicago Illinois U.S.A.
2 shared publicationsAli McAllister-Day
University of Missouri School of Medicine
1 shared publication- Brian E. Caplan
Midwest Orthopaedics at Rush University Medical Center Chicago Illinois U.S.A.
1 shared publication - Brian J. Cole
Midwest Orthopaedics at Rush University Medical Center Chicago Illinois U.S.A.
1 shared publication
Latest Publications
- 29 October 2026
- Published by Wiley in Arthroscopy
A Digital Ecosystem Using Artificial Intelligence Solutions in Musculoskeletal Health Care
The number of artificial intelligence (AI) use cases relevant to health care has continued to increase substantially because technology has evolved. For orthopaedic surgeons and musculoskeletal providers, the onus has expanded beyond learning about these tools conceptually and shifted toward understanding how to use them in everyday clinical workflows. There is a perceived opportunity cost from ignoring these use cases and, similarly, an operational cost from excessively implementing AI tools without thoughtful consideration of how they may impact patient care. This infographic shows how orthopaedic surgeons may leverage various AI solutions to create a digital ecosystem that portends efficiency and value. Before a patient formally establishes care with a physician, AI solutions leveraging agentic frameworks may assist with scheduling appointments based on screening criteria, informing patients of outstanding laboratory or imaging requests, and curating physicians’ schedules. During appointments, physicians can leverage ambient scribes, which listen to patient‐physician encounters and automatically synthesize clinical notes, to make visits more efficient. Furthermore, more recent iterations of scribes automatically codify diagnoses and treatments using International Classification of Diseases, 10th Revision and Current Procedural Terminology and prepopulate orders. The Hospital for Special Surgery, Cleveland Clinic, and Kaiser Permanente, among many others, have used these pipelines to reduce administrative burden and allow more time for direct patient interactions. Multimodal models trained on vast amounts of imaging data may allow for intelligent diagnosis of musculoskeletal pathologies; however, several advanced solutions allow physicians to create “digital twins” and model patient‐specific pathology to guide surgical techniques and predict optimal placement of grafts, implants, and/or tunnels. Postoperatively, physicians can leverage practice‐specific guidelines to create asynchronous chat agents to increase adherence to rehabilitation guidelines. Wearable devices allow real‐time transmission of motion data to help physicians understand recovery trajectory and progress against milestones. Important ethical questions remain. Patient privacy is paramount, requiring enterprise agreements with AI vendors to ensure data remains Health Insurance Portability and Accountability Act‐compliant. Furthermore, systems need to implement governing boards, regular audits, and safety guardrails to ensure data safety and appropriate model performance. Significant literacy gaps remain among patients in underserved communities, so physicians must consider equitable AI implementation. As models progress in capability and speed and become less costly, physicians have exciting avenues to optimize clinical workflows and free more time for empathetic, patient‐guided care.
- 29 October 2026
- Published by Wiley in Arthroscopy
A Digital Ecosystem Using Artificial Intelligence Solutions in Musculoskeletal Health Care
The number of artificial intelligence (AI) use cases relevant to health care has continued to increase substantially because technology has evolved. For orthopaedic surgeons and musculoskeletal providers, the onus has expanded beyond learning about these tools conceptually and shifted toward understanding how to use them in everyday clinical workflows. There is a perceived opportunity cost from ignoring these use cases and, similarly, an operational cost from excessively implementing AI tools without thoughtful consideration of how they may impact patient care. This infographic shows how orthopaedic surgeons may leverage various AI solutions to create a digital ecosystem that portends efficiency and value. Before a patient formally establishes care with a physician, AI solutions leveraging agentic frameworks may assist with scheduling appointments based on screening criteria, informing patients of outstanding laboratory or imaging requests, and curating physicians’ schedules. During appointments, physicians can leverage ambient scribes, which listen to patient‐physician encounters and automatically synthesize clinical notes, to make visits more efficient. Furthermore, more recent iterations of scribes automatically codify diagnoses and treatments using International Classification of Diseases, 10th Revision and Current Procedural Terminology and prepopulate orders. The Hospital for Special Surgery, Cleveland Clinic, and Kaiser Permanente, among many others, have used these pipelines to reduce administrative burden and allow more time for direct patient interactions. Multimodal models trained on vast amounts of imaging data may allow for intelligent diagnosis of musculoskeletal pathologies; however, several advanced solutions allow physicians to create “digital twins” and model patient‐specific pathology to guide surgical techniques and predict optimal placement of grafts, implants, and/or tunnels. Postoperatively, physicians can leverage practice‐specific guidelines to create asynchronous chat agents to increase adherence to rehabilitation guidelines. Wearable devices allow real‐time transmission of motion data to help physicians understand recovery trajectory and progress against milestones. Important ethical questions remain. Patient privacy is paramount, requiring enterprise agreements with AI vendors to ensure data remains Health Insurance Portability and Accountability Act‐compliant. Furthermore, systems need to implement governing boards, regular audits, and safety guardrails to ensure data safety and appropriate model performance. Significant literacy gaps remain among patients in underserved communities, so physicians must consider equitable AI implementation. As models progress in capability and speed and become less costly, physicians have exciting avenues to optimize clinical workflows and free more time for empathetic, patient‐guided care.
- 6 September 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (11) , 2405-2407
Editorial Commentary : Calling Balls and Strikes: For Artificial Intelligence Models to Accurately Predict Rotator Cuff Retear, We Must Carefully Define the Strike Zone
Early retear is a devastating complication following arthroscopic rotator cuff repair. The ability to predict early retear in patients undergoing rotator cuff repair may allow for interventions targeted at mitigating the risk of this complication, thereby improving surgical outcomes. Transfer learning, wherein labeled datasets are used to repurpose pretrained convolutional neural networks, represents an important approach for potentially improving the accuracy of these predictions through using artificial intelligence and deep learning. Leveraging deep learning provides an alternative approach to using tabular data for predictions by extracting important and subtle data from imaging (such as arthroscopic photographs) to provide insight into how the appearance of a surgical construct may predict outcomes. However, the value of such pipelines depends highly on preprocessing and generalizability of the training datasets. When labeling datasets, characteristics such as tendon integrity may be partially subjective, so surgeon‐versus‐surgeon (interrater) reliability or surgeon‐versus‐model analysis is crucial towards reducing bias. Clinical adoption of these pipelines requires generalizability of models, and convolutional neural networks trained on single surgeon datasets introduces bias variability. Clinical adoption requires trust and fairness as well as governance by artificial intelligence regulatory committees or “umpires;” and, if we are to trust DL models to call balls and strikes with respect to rotator cuff integrity in the real‐world, it is important to have a clearly defined strike‐zone.
- 6 September 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (11) , 2405-2407
Editorial Commentary : Calling Balls and Strikes: For Artificial Intelligence Models to Accurately Predict Rotator Cuff Retear, We Must Carefully Define the Strike Zone
Early retear is a devastating complication following arthroscopic rotator cuff repair. The ability to predict early retear in patients undergoing rotator cuff repair may allow for interventions targeted at mitigating the risk of this complication, thereby improving surgical outcomes. Transfer learning, wherein labeled datasets are used to repurpose pretrained convolutional neural networks, represents an important approach for potentially improving the accuracy of these predictions through using artificial intelligence and deep learning. Leveraging deep learning provides an alternative approach to using tabular data for predictions by extracting important and subtle data from imaging (such as arthroscopic photographs) to provide insight into how the appearance of a surgical construct may predict outcomes. However, the value of such pipelines depends highly on preprocessing and generalizability of the training datasets. When labeling datasets, characteristics such as tendon integrity may be partially subjective, so surgeon‐versus‐surgeon (interrater) reliability or surgeon‐versus‐model analysis is crucial towards reducing bias. Clinical adoption of these pipelines requires generalizability of models, and convolutional neural networks trained on single surgeon datasets introduces bias variability. Clinical adoption requires trust and fairness as well as governance by artificial intelligence regulatory committees or “umpires;” and, if we are to trust DL models to call balls and strikes with respect to rotator cuff integrity in the real‐world, it is important to have a clearly defined strike‐zone.
- Open Access
- 23 July 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (9) , 1475-1478
Orthobiologics Research Continues to Advance Modern Musculoskeletal Care of Patients: The Fourth Annual Arthroscopy : The Journal of Arthroscopic and Related Surgery Orthobiologics Special Issue
Orthobiologics are a rapidly innovative field of musculoskeletal science and clinical care, aiding in sports medicine and joint preservation to improve biologic healing, modulate inflammation, and improve clinical outcomes. Large scale randomized controlled trials and subsequent adoption into clinical practice are only possible because of a collective scientific effort to advance the field through meticulous basic science and clinical study. In the Fourth Annual Orthobiologics Special Issue, presented by Arthroscopy : The Journal of Arthroscopic and Related Surgery , we present a collection of articles which represents the frontier of Orthobiologics research in the Arthroscopy Family of Journals. International collaborative initiatives have studied Orthobiologics in the laboratory, across sports medicine and cartilage restoration procedures in the shoulder, elbow, hip, knee, and ankle through clinical studies and technique videos and crystallized results through systematic review and meta‐analysis. The important scientific questions behind Orthobiologics are much broader than proving efficacy; clinicians and scientists must think much bigger: Which preparations are most likely to yield superior outcomes? How can variation in augmentation and delivery techniques influence healing trajectories? What are important considerations for physicians as they adopt Orthobiologics into clinical practice? To that end, we highlight the meaningful advances that scientists have made in answering those questions, along with the exciting white space representing the answers that remain, and the new questions generated for the next generation of Orthobiologics’ study.
- 23 July 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (9) , 1475-1478
Open AccessOrthobiologics Research Continues to Advance Modern Musculoskeletal Care of Patients: The Fourth Annual Arthroscopy : The Journal of Arthroscopic and Related Surgery Orthobiologics Special Issue
Orthobiologics are a rapidly innovative field of musculoskeletal science and clinical care, aiding in sports medicine and joint preservation to improve biologic healing, modulate inflammation, and improve clinical outcomes. Large scale randomized controlled trials and subsequent adoption into clinical practice are only possible because of a collective scientific effort to advance the field through meticulous basic science and clinical study. In the Fourth Annual Orthobiologics Special Issue, presented by Arthroscopy : The Journal of Arthroscopic and Related Surgery , we present a collection of articles which represents the frontier of Orthobiologics research in the Arthroscopy Family of Journals. International collaborative initiatives have studied Orthobiologics in the laboratory, across sports medicine and cartilage restoration procedures in the shoulder, elbow, hip, knee, and ankle through clinical studies and technique videos and crystallized results through systematic review and meta‐analysis. The important scientific questions behind Orthobiologics are much broader than proving efficacy; clinicians and scientists must think much bigger: Which preparations are most likely to yield superior outcomes? How can variation in augmentation and delivery techniques influence healing trajectories? What are important considerations for physicians as they adopt Orthobiologics into clinical practice? To that end, we highlight the meaningful advances that scientists have made in answering those questions, along with the exciting white space representing the answers that remain, and the new questions generated for the next generation of Orthobiologics’ study.
- Open Access
- 17 July 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (4) , 100820
Sleep disturbance in patients undergoing shoulder surgery: a current concepts review
- 17 July 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (4) , 100820
Open AccessSleep disturbance in patients undergoing shoulder surgery: a current concepts review
- Open Access
- 18 May 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (10) , 1943-1945
Editorial Commentary : Rotator Cuff Repair Augmentation: Arguably the Only Meaningful Improvement in Rotator Cuff Repair Outcomes in Last 40 Years, While Being Cost‐Effective
Rotator cuff repair (RCR) remains one of the most commonly performed orthopaedic procedures and represents a dynamic scientific evolution. This progression toward optimizing patient outcomes has certainly been nonlinear, and it requires that we ask of ourselves: have advances in RCR delivered on this promise? Advances in surgical approach, repair configuration, and the introduction of marrow stimulation have produced largely equivalent outcomes, leaving retear rates persistently high, especially for large and massive tears. To that end, structural augmentation with allograft or xenograft has emerged as a notable exception, showing lower retear rates, improved functional outcomes, and structural integrity across multiple cohorts when compared with primary RCR alone. Despite a higher upfront cost and increased operative complexity, recent cost‐effectiveness analyses affirm that allograft augmentation yields an incremental cost‐effectiveness ratio within acceptable thresholds. This may challenge the philosophy that augmentation ought to be reserved only for revision or complex RCR. Xenograft, while cost‐effective by some estimates, may represent a significantly higher complication profile without corresponding improvements in healing or function. The accumulating evidence positions allograft structural augmentation as arguably the only advancement in RCR that has delivered on the process of improving patient outcomes, and importantly, it does so while maintaining cost effectiveness.
- 18 May 2026
- Published by Wiley in Arthroscopy
- Vol. 42 (10) , 1943-1945
Open AccessEditorial Commentary : Rotator Cuff Repair Augmentation: Arguably the Only Meaningful Improvement in Rotator Cuff Repair Outcomes in Last 40 Years, While Being Cost‐Effective
Rotator cuff repair (RCR) remains one of the most commonly performed orthopaedic procedures and represents a dynamic scientific evolution. This progression toward optimizing patient outcomes has certainly been nonlinear, and it requires that we ask of ourselves: have advances in RCR delivered on this promise? Advances in surgical approach, repair configuration, and the introduction of marrow stimulation have produced largely equivalent outcomes, leaving retear rates persistently high, especially for large and massive tears. To that end, structural augmentation with allograft or xenograft has emerged as a notable exception, showing lower retear rates, improved functional outcomes, and structural integrity across multiple cohorts when compared with primary RCR alone. Despite a higher upfront cost and increased operative complexity, recent cost‐effectiveness analyses affirm that allograft augmentation yields an incremental cost‐effectiveness ratio within acceptable thresholds. This may challenge the philosophy that augmentation ought to be reserved only for revision or complex RCR. Xenograft, while cost‐effective by some estimates, may represent a significantly higher complication profile without corresponding improvements in healing or function. The accumulating evidence positions allograft structural augmentation as arguably the only advancement in RCR that has delivered on the process of improving patient outcomes, and importantly, it does so while maintaining cost effectiveness.
- 25 June 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
What Proportion of Pediatric Surgical Cases are Performed by Early Career Pediatric Orthopaedic Surgeons? A 17-Year Study Using the ABOS Database
Background: Orthopaedic surgery residency graduates are more likely to pursue subspecialty fellowship training than ever before. Pediatric fellowship positions have doubled over the last 20 years, and fellowship accreditation requirements have changed within the last decade. However, little research exists on the effect of increased pediatric fellowship graduates on who provides orthopaedic care to children. We hypothesize that the proportion of pediatric orthopaedic cases performed by pediatric surgeons has increased over the past 2 decades, compared with adult counterparts. Methods: Procedure logs of applicants for American Board of Orthopaedic Surgery (ABOS) part II certification from 2005 to 2022 were collected. Applicants are divided into pediatric and adult orthopaedic surgeons, and reports include Current Procedural Terminology (CPT) codes to specify the exact medical care provided. Using descriptive and statistical analysis, we quantified trends on the proportion of orthopaedic care in pediatric patients provided by pediatric surgeons compared with their adult counterparts over a 17-year period. We stratified trends by age, comparing “child” (PP<0.01). Similar increases were exhibited when stratified by age. Conclusions: Over a 17-year span, pediatric surgeons perform a greater proportion of pediatric orthopaedic cases. When stratifying by patient age or by the top 10 most performed procedures, these trends persist. However, most pediatric cases are still performed by adult surgeons, underscoring the importance of pediatric training in general orthopaedic residency. Level of Evidence: Level III.
- 25 June 2025
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
What Proportion of Pediatric Surgical Cases are Performed by Early Career Pediatric Orthopaedic Surgeons? A 17-Year Study Using the ABOS Database
Background: Orthopaedic surgery residency graduates are more likely to pursue subspecialty fellowship training than ever before. Pediatric fellowship positions have doubled over the last 20 years, and fellowship accreditation requirements have changed within the last decade. However, little research exists on the effect of increased pediatric fellowship graduates on who provides orthopaedic care to children. We hypothesize that the proportion of pediatric orthopaedic cases performed by pediatric surgeons has increased over the past 2 decades, compared with adult counterparts. Methods: Procedure logs of applicants for American Board of Orthopaedic Surgery (ABOS) part II certification from 2005 to 2022 were collected. Applicants are divided into pediatric and adult orthopaedic surgeons, and reports include Current Procedural Terminology (CPT) codes to specify the exact medical care provided. Using descriptive and statistical analysis, we quantified trends on the proportion of orthopaedic care in pediatric patients provided by pediatric surgeons compared with their adult counterparts over a 17-year period. We stratified trends by age, comparing “child” (PP<0.01). Similar increases were exhibited when stratified by age. Conclusions: Over a 17-year span, pediatric surgeons perform a greater proportion of pediatric orthopaedic cases. When stratifying by patient age or by the top 10 most performed procedures, these trends persist. However, most pediatric cases are still performed by adult surgeons, underscoring the importance of pediatric training in general orthopaedic residency. Level of Evidence: Level III.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (3) , H565-H580
Cardiac health, type I collagen, and aging in the oim/oim mouse model of osteogenesis imperfecta and a cohort of adults with OI
The heritable skeletal dysplasia, osteogenesis imperfecta (OI), recently recognized as a pleiotropic collagenopathy, shows growing evidence of cardiac involvement impacting lifespan. Evaluating cardiac function (magnetic resonance imaging and echocardiography) using an OI mouse model revealed increased left ventricular end-diastolic and end-systolic volumes concomitant with decreased function and reduced survival in 18-mo-old male OI mice. Additional cardiac evaluations of an adult patient cohort with OI corroborated increased incidences of valvular dysfunction in the patient population with OI.
- 1 March 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (3) , H565-H580
Cardiac health, type I collagen, and aging in the oim/oim mouse model of osteogenesis imperfecta and a cohort of adults with OI
The heritable skeletal dysplasia, osteogenesis imperfecta (OI), recently recognized as a pleiotropic collagenopathy, shows growing evidence of cardiac involvement impacting lifespan. Evaluating cardiac function (magnetic resonance imaging and echocardiography) using an OI mouse model revealed increased left ventricular end-diastolic and end-systolic volumes concomitant with decreased function and reduced survival in 18-mo-old male OI mice. Additional cardiac evaluations of an adult patient cohort with OI corroborated increased incidences of valvular dysfunction in the patient population with OI.
- 5 June 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (17) , 1594-1599
Pediatric Device Innovation
Background: Despite a tremendous increase in the number of orthopaedic devices authorized by the U.S. Food and Drug Administration (FDA), novel devices designed specifically for the pediatric population remain sparse. Surgeons frequently repurpose adult implants for “off-label” use in pediatric patients, with both legal and technical ramifications. This study seeks to objectively quantify and characterize the nature of pediatric device innovation over time. Methods: The FDA employs 4 pathways for assessing safety and effectiveness of novel devices prior to authorization. Perceived device risk and novelty determine the pathway. Orthopaedic devices were identified from the FDA’s online database. All devices approved since inception via the Humanitarian Device Exemption, Pre-Market Approval, and De Novo regulatory pathways were included and grouped as “highly innovative.” Because of their number and the rapidity of their development, the evaluation of 510(k) devices was limited to those cleared from January 1, 2018, to December 31, 2022. Such 510(k) devices make up ∼97% of devices and by definition are less risky and less novel. Approval statements were assessed for pediatric indications within the approved labeling. As a secondary analysis, the impact of company size on developing a product with a pediatric indication was analyzed. Results: Of the 1,925 devices cleared via the 510(k) pathway, 9 (0.5%) were designed exclusively for pediatrics and 160 (8.3%) included pediatric indications. Five of the 9 pediatrics-only devices were for spine and 4 were for trauma indications. Of the 97 highly innovative devices, only 2 (2%) were exclusively pediatric and another 2 (2%) included pediatric indications. The 2 pediatrics-only devices were for the spine. Large and medium-sized companies were 1.9 times and 1.6 times more likely to bring to market a device with pediatric indications than a small company, respectively. Conclusions: Innovation for pediatric orthopaedic devices lags substantially behind that for adult orthopaedic devices. These findings are consistent with clinical experience and the common practice of modifying adult implants for “off-label” use in pediatric patients. Despite long-standing efforts to stimulate innovation for this vulnerable population, our results suggest little progress.
- 5 June 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 106 (17) , 1594-1599
Pediatric Device Innovation
Background: Despite a tremendous increase in the number of orthopaedic devices authorized by the U.S. Food and Drug Administration (FDA), novel devices designed specifically for the pediatric population remain sparse. Surgeons frequently repurpose adult implants for “off-label” use in pediatric patients, with both legal and technical ramifications. This study seeks to objectively quantify and characterize the nature of pediatric device innovation over time. Methods: The FDA employs 4 pathways for assessing safety and effectiveness of novel devices prior to authorization. Perceived device risk and novelty determine the pathway. Orthopaedic devices were identified from the FDA’s online database. All devices approved since inception via the Humanitarian Device Exemption, Pre-Market Approval, and De Novo regulatory pathways were included and grouped as “highly innovative.” Because of their number and the rapidity of their development, the evaluation of 510(k) devices was limited to those cleared from January 1, 2018, to December 31, 2022. Such 510(k) devices make up ∼97% of devices and by definition are less risky and less novel. Approval statements were assessed for pediatric indications within the approved labeling. As a secondary analysis, the impact of company size on developing a product with a pediatric indication was analyzed. Results: Of the 1,925 devices cleared via the 510(k) pathway, 9 (0.5%) were designed exclusively for pediatrics and 160 (8.3%) included pediatric indications. Five of the 9 pediatrics-only devices were for spine and 4 were for trauma indications. Of the 97 highly innovative devices, only 2 (2%) were exclusively pediatric and another 2 (2%) included pediatric indications. The 2 pediatrics-only devices were for the spine. Large and medium-sized companies were 1.9 times and 1.6 times more likely to bring to market a device with pediatric indications than a small company, respectively. Conclusions: Innovation for pediatric orthopaedic devices lags substantially behind that for adult orthopaedic devices. These findings are consistent with clinical experience and the common practice of modifying adult implants for “off-label” use in pediatric patients. Despite long-standing efforts to stimulate innovation for this vulnerable population, our results suggest little progress.
- Open Access
- 9 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48571
Challenges of Management of Subaortic Membrane in a Young Adult Patient: A Case Report
This article presents a case review and literature review focused on the challenges of managing subaortic membranes (SAMs) in young adult patients with mild aortic regurgitation (AR) or aortic stenosis (AS). The study aims to discuss the diagnosis of SAM, the imaging studies used for assessment, the management strategies in young patients, the risk of valvular damage, and the controversy surrounding prophylactic resection in mild AR. The management of SAM in adults poses challenges due to limited treatment options and potential complications, necessitating further investigation into the progression of AS and AR in asymptomatic SAM patients. The case presentation describes a 40-year-old male with muscular dystrophy who presented with symptoms and was diagnosed with SAM. Various imaging techniques, including CT chest, transthoracic echocardiogram (TTE), and transesophageal echocardiogram (TEE), were used to confirm the presence and severity of SAM. Based on the patient's clinical profile and the absence of surgical indications, medical therapy was initiated, and regular outpatient follow-up was recommended to monitor disease progression. The discussion highlights the challenges in diagnosing SAM, the importance of imaging studies, and the potential complications associated with SAM in young patients. The article also explores the management options for SAM, emphasizing surgical resection as the definitive treatment, while acknowledging the limited success rates of alternative approaches. Close monitoring and prompt intervention for complications are crucial in the management of SAM. The concluding statement emphasizes the need for further research to explore alternative treatments for SAM in young patients.
- 9 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e48571
Open AccessChallenges of Management of Subaortic Membrane in a Young Adult Patient: A Case Report
This article presents a case review and literature review focused on the challenges of managing subaortic membranes (SAMs) in young adult patients with mild aortic regurgitation (AR) or aortic stenosis (AS). The study aims to discuss the diagnosis of SAM, the imaging studies used for assessment, the management strategies in young patients, the risk of valvular damage, and the controversy surrounding prophylactic resection in mild AR. The management of SAM in adults poses challenges due to limited treatment options and potential complications, necessitating further investigation into the progression of AS and AR in asymptomatic SAM patients. The case presentation describes a 40-year-old male with muscular dystrophy who presented with symptoms and was diagnosed with SAM. Various imaging techniques, including CT chest, transthoracic echocardiogram (TTE), and transesophageal echocardiogram (TEE), were used to confirm the presence and severity of SAM. Based on the patient's clinical profile and the absence of surgical indications, medical therapy was initiated, and regular outpatient follow-up was recommended to monitor disease progression. The discussion highlights the challenges in diagnosing SAM, the importance of imaging studies, and the potential complications associated with SAM in young patients. The article also explores the management options for SAM, emphasizing surgical resection as the definitive treatment, while acknowledging the limited success rates of alternative approaches. Close monitoring and prompt intervention for complications are crucial in the management of SAM. The concluding statement emphasizes the need for further research to explore alternative treatments for SAM in young patients.